aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
© aVenture Investment Company, 2024. All rights reserved.
44 Tehama St, San Francisco, CA 94105
Privacy Policy
aVenture Investment Company ("aVenture") is an independent venture capital research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals.
While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision.
aVenture does not offer investment advisory services and is not registered as an investment adviser. The data provided by aVenture does not constitute recommendations or advice, whether by methodology or a statement written by a staff member of aVenture.
Links to external websites do not imply endorsement or affiliation with aVenture. References or links to providers offering the ability to invest in a primary or secondary transaction in a company are for convenience purposes only. They are not solicitations or offers to buy or sell an investment. Remember that past performance does not guarantee future results, and venture capital and private assets should be a contributory part of a diversified portfolio.
Pretzel Therapeutics was founded by leading academics in mitochondrial biology and is driven by a mission to develop life-changing medicines for patients and families affected by mitochondrial diseases. The company focuses on understanding and targeting the underlying causes of these diseases rather than just addressing symptoms. Pretzel Therapeutics leverages cutting-edge research in mitochondrial biology to discover and develop new treatments, aiming to create a new treatment paradigm in the field of mitochondrial therapeutics.
The company benefits from the leadership of experts in drug discovery, development, and company formation. Notable affiliated individuals include accomplished scientists and industry veterans who bring a wealth of experience to the organization. Pretzel Therapeutics has made significant strides in its field, contributing to a deeper understanding of mitochondrial diseases and advancing potential therapies. The impact of their work holds promise for improving the lives of thousands of people with genetic mitochondrial conditions.
Operating Status
Active
Ownership Type(s)
Venture Capital
Main Product(s)
Drug Discovery
Technology
Biotech
Tags
Healthtech
Model Types
Software
Revenue Type(s)
Recurring
Customer Type(s)
Enterprise
Geographic Exposure
Global
When was Pretzel Therapeutics founded?
Pretzel Therapeutics was founded in 2019.
Where is Pretzel Therapeutics’s headquarters located?
Pretzel Therapeutics’s headquarters is located in Boston, MA, US.
When was Pretzel Therapeutics’s last funding round?
Pretzel Therapeutics’s most recent funding round was for $72.5M (USD) in September 2022.
How many employees does Pretzel Therapeutics have?
Pretzel Therapeutics has 42 employees as of Feb 4, 2024.
How much has Pretzel Therapeutics raised to-date?
As of July 05, 2023, Pretzel Therapeutics has raised a total of $72.5M (USD) since Sep 12, 2022.
Add Comparison
Total Raised to Date
$72.5M
USD
Last Update Sep 12, 2022
Last Deal Details
$72.5M
USD
Sep 12, 2022
Series A
Total Employees Over Time
42
As of Feb 2024
Pretzel Therapeutics Address
Boston,
Massachusetts
02110
United States
Source(s): This page includes data and analysis provided by the company, OpenAI, and our research analysts